NTR

Briefing From The Editor -- NTR Stock

Now trading at a price of $50.8, Nutrien has moved 5.0% so far today.

Nutrien returned losses of -10.1% last year, with its stock price reaching a high of $60.87 and a low of $44.65. Over the same period, the stock underperformed the S&P 500 index by -41.4%. AThe company's 50-day average price was $47.84. Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. Based in Saskatoon, Canada, the Large-Cap Industrials company has 25,900 full time employees. Nutrien has offered a 4.4% dividend yield over the last 12 months.

Generally Positive Cash Flows but a Declining EPS Growth Trend:

2018 2019 2020 2021 2022 2023
Revenue (M) $19,636 $20,084 $20,908 $27,712 $37,884 $29,056
Gross Margins 27% 27% 25% 34% 41% 28%
Net Margins 18% 5% 2% 11% 20% 4%
Net Income (M) $3,573 $992 $459 $3,179 $7,687 $1,282
Earnings Per Share $5.72 $1.7 $0.81 $5.52 $14.18 $2.53
EPS Growth n/a -70.28% -52.35% 581.48% 156.88% -82.16%
Free Cash Flow (M) $2,052 $3,665 $3,323 $3,886 $8,110 $5,066
Total Debt (M) $7,579 $8,553 $10,047 $7,521 $8,040 $8,913
Net Debt / EBITDA 2.62 2.15 2.97 1.04 0.56 1.62
Current Ratio 1.4 1.17 1.35 1.11 1.14 1.17

Nutrien Shares Are Inexpensive:

Nutrien has a trailing twelve month P/E ratio of 29.9, compared to an average of 25.42 for the Industrials sector. Based on its EPS guidance of $4.01, the company has a forward P/E ratio of 11.9. The -4.9% compound average growth rate of Nutrien's historical and projected earnings per share yields a PEG ratio of -6.04. This indicates that its shares are overvalued.In contrast, the market is likely undervaluing Nutrien in terms of its equity because its P/B ratio is 1.0 while the sector average is 3.2.

Nutrien Has an Average Rating of Buy:

The 18 analysts following Nutrien have set target prices ranging from $48.0 to $75.0 per share, for an average of $59.39 with a buy rating. The company is trading -14.5% away from its average target price, indicating that there is an analyst consensus of some upside potential.

Nutrien has a very low short interest because 1.7% of the company's shares are sold short. Institutions own 72.1% of the company's shares, and the insider ownership rate stands at 0.03%, suggesting a small amount of insider investors. The largest shareholder is Royal Bank of Canada, whose 7% stake in the company is worth $1,645,191,588.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS